NextCure reports Q3 2026 results as Avere merger financing grows to $820 millionNov 10Quarterly updateNextCure, Inc.
NextCure reports Q2 2026 results, moves toward Avere Therapeutics mergerAug 6Quarterly updateNextCure, Inc.